Lucibelzu

Sobre este medicamento

Originator: WELIREG by MERCK SHARP DOHME · Manufacturer: Lucius Pharma. Indication & Dosage: Lucibelzu (Belzutifan), generic WELIREG is a prescription medicine used to treat of adult patients with von Hippel-Lindau (VHL) disease. Belzutifan is indicated for use in patients who require therapy for associated renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastomas, or pancreatic neuroendocrine tumors (pNET), and who do not require immediate surgical intervention. Lucibelzu manufactured by Lucius Pharmaceutical Co. Ltd. in Laos. Belzutifan has to take orally once a day with or without food as directed by patient’s doctor. Side Effects: The most common side effects of Belzutifan are: Nausea , vomiting , constipation , abdominal pain , muscle/joint pain , dizziness, or headache. The above information comes from the Internet. Please consult with doctor for medical advice.

Esta información es solo de referencia y no constituye consejo médico. Consulte siempre a un profesional de la salud calificado.